Install
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V
- 339articles · 30d
- 2+ day agolatest article
- Aug 17, 2026earliest in window
- 92%with images
- 291avg words
- Economy, Business & Finance 195
- Health & Wellness 158
- Medical 157
- Business & Industrial 142
- Finance & Business 132
- Health 74
- Science & Technology 53
- Science & Nature 34
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Olympus Announces New Class of iTind™ Center of Excellence Program Physicians
2+ day, 15+ hour ago (457+ words) Program Aims to Advance Minimally Invasive Treatment of Enlarged Prostate CENTER VALLEY, Pa., Sept. 10, 2026 /PRNewswire/ -- Olympus Corp. of the Americas (Olympus) is pleased to announce the newest members of the iTind™ Center of Excellence (COE) Program, which is designed to…...
Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline
3+ day, 6+ hour ago (429+ words) BioSpace Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline CAMBRIDGE, England--(BUSINESS WIRE)--Clinical-stage biotech Alchemab Therapeutics has appointed experienced pharma and biotech leader Dr Ben Porter-Brown as Chief…...
Retension Pharmaceuticals Appoints LeAnne Bloedon, M.S., RD, as EVP of Clinical Development and Operations, and Kevin Schutz, PharmD, as VP Regulatory Affairs
3+ day, 2+ hour ago (140+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...
Tenpoint Therapeutics to Participate in Upcoming Investor Conferences and Medical Meetings
4+ day, 3+ hour ago (200+ words) BioSpace Tenpoint Therapeutics to Participate in Upcoming Investor Conferences and Medical Meetings LONDON & WARREN, N.J.--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced participation…...
Solstice rises with $225M to develop next-gen CTLA-4 drug from China
4+ day, 6+ hour ago (303+ words) A new cancer biotech has dawned as Solstice Oncology launches with a massive $225 million Series A fundraising that will be used to advance a CTLA-4 antibody from China’s Harbour BioMed. Solstice CEO Caroline Loew said the mission will be to…...
GenSight Biologics Provides September 2026 Business Updates
5+ day, 7+ hour ago (181+ words) The results to date have already triggered the preparations for the manufacture of the GMP batch that will be used to sustain product supply for the Company’s early access programs. Update on Clinical Activities All remaining patients planned for the…...
Stoke Therapeutics to Present at the Cantor Global Healthcare Conference
1+ week, 4+ day ago (290+ words) BioSpace Stoke Therapeutics to Present at the Cantor Global Healthcare Conference BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a…...
Calluna Pharma Announces Participation in Upcoming Scientific and Investor Conferences
1+ week, 5+ day ago (209+ words) Company to highlight Phase 2 AURORA study of CAL101 in IPF ahead of planned Q1 2027 readout European Respiratory Society (ERS) Congress 2026 Barcelona, Spain Sept. 5–9, 2026 Jonas Hallen, M.D., Ph.D. (CMO) and Toby Maher, M.D., Ph.D. (Coordinating Investigator on the AURORA study) will…...
Exonate Becomes Foventa Therapeutics
1+ week, 5+ day ago (336+ words) biospace.com Exonate Becomes Foventa Therapeutics - The new name, which takes inspiration from the fovea, marks the company's transition to focus on clinical development in non-proliferative diabetic retinopathy. - In earlier clinical trials, FOV407 exhibited remarkable ability to suppress harmful vascular leakage…...
Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21st Annual Wells Fargo Healthcare Conference
1+ week, 6+ day ago (213+ words) BioSpace Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21st Annual Wells Fargo Healthcare Conference BOSTON--(BUSINESS WIRE)--Seaport Therapeutics, Inc. (Nasdaq: SPTX) (“Seaport” or the “Company”), a clinical-stage therapeutics company that is inventing and…...